![Jay Schiestle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jay Schiestle is currently the Vice President-Operations at Lucigen Corp.
He holds an MBA from Duke University and an undergraduate degree from Marquette University.
Aktive Positionen von Jay Schiestle
Unternehmen | Position | Beginn |
---|---|---|
Lucigen Corp.
![]() Lucigen Corp. Pharmaceuticals: MajorHealth Technology Lucigen Corp. engages in the development, manufacture, and sale of biomedical research products and services. The firm offers products for array-based analysis; cloning kits and vectors; competent cells; enzymes; in vitro transcription; next gen sequencing (NGS); nucleic acid extraction and purification; PCR and amplification; protein expression; and transposon mutagenesis. It also provides NGS and custom competent cell services. The company was founded by David Mead and Thomas W. Schoenfeld in 1998 and is headquartered in Middleton, WI. | Geschäftsführer | 01.04.2015 |
Ausbildung von Jay Schiestle
Marquette University | Undergraduate Degree |
Duke University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Lucigen Corp.
![]() Lucigen Corp. Pharmaceuticals: MajorHealth Technology Lucigen Corp. engages in the development, manufacture, and sale of biomedical research products and services. The firm offers products for array-based analysis; cloning kits and vectors; competent cells; enzymes; in vitro transcription; next gen sequencing (NGS); nucleic acid extraction and purification; PCR and amplification; protein expression; and transposon mutagenesis. It also provides NGS and custom competent cell services. The company was founded by David Mead and Thomas W. Schoenfeld in 1998 and is headquartered in Middleton, WI. | Health Technology |